Protection against Experimental Allergic Encephalomyelitis

No abstract is available for this paper.

• Publication year

  1972

• Venue

  Nature

• Publication date

  1972-12-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/240564B0PMID 4119624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phage DNA directed enzyme synthesis in vitro system from yeast mitochondria.

  1972cited by this paper
• Suppression of the Immune Response: Reversal of the Disease State with Antigen in Allergic Encephalomyelitis

  1972cited by this paper
• Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

  1971cited by this paper
• Dissociation of antibody production from disease suppression in the inhibition of allergic encephalomyelitis by myelin basic protein.

  1970cited by this paper
• Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitis.

  1968cited by this paper
• Experimental allergic encephalomyelitis and autoimmune disease.

  1966cited by this paper
• Specificity of encephalitogen-induced inhibition of experimental "allergic" encephalomyelitis in the guinea pig.

  1962cited by this paper
• ADJUVANT-ANTIGEN RELATIONSHIPS IN THE PRODUCTION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG

  1962cited by this paper
• SUPPRESSION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN GUINEA PIGS BY ENCEPHALITOGENIC PROTEINS EXTRACTED FROM HOMOLOGOUS BRAIN

  1960cited by this paper
• Factors affecting the suppression of allergic encephalomvelitis by homologous brain protein fractions.

  1960cited by this paper
• Various Types of Acquired Resistance to Experimental ‘Allergic’ Encephalomyelitis

  1959cited by this paper
• Acquired Resistance to Experimental Allergic Encephalomyelitis

  1958cited by this paper

• Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications

  2017cites this paper
• A Journey in Science: The Privilege of Exploring the Brain and the Immune System

  2016cites this paper
• From defining antigens to new therapies in multiple sclerosis: honoring the contributions of Ruth Arnon and Michael Sela.

  2014cites this paper
• Engineering of synthetic cellular microenvironments: implications for immunity.

  2014cites this paper
• Analyzing the effects of laquinimod on innate and adaptive immunity in mice with experimental autoimmune encephalomyelitis

  2014cites this paper
• Critical appraisal of animal models of multiple sclerosis

  2011cites this paper
• Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome.

  2011cites this paper
• B-cell delivered gene therapy for tolerance induction: role of autoantigen-specific B cells.

  2010cites this paper
• Translational research in neurology and neuroscience 2010-2011.

  2010cites this paper
• Translational research in neurology and neuroscience 2010: multiple sclerosis.

  2010cites this paper
• Glatiramer acetate: mechanisms of action in multiple sclerosis.

  2007cites this paper
• Glatiramer acetate: mechanisms of action in multiple sclerosis.

  2007cites this paper
• How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis

  2006cites this paper
• Antigen-Specific Therapies in Multiple Sclerosis: Going Beyond Proteins and Peptides

  2005cites this paper
• Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.

  2005cites this paper
• Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapy.

  2005cites this paper
• What do we know about the mechanism of action of disease-modifying treatments in MS?

  2004cites this paper
• Neuroprotection and glatiramer acetate: the possible role in the treatment of multiple sclerosis.

  2004cites this paper
• Behandlung der multiplen Sklerose

  2003cites this paper
• Behandlung der Multiplen Sklerose mit Glatiramer-Azetat

  2002cites this paper
• Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor.

  2002cites this paper
• [Treatment of multiple sclerosis with glatiramer acetate. Current aspects of mechanisms of action, pharmacokinetics, adverse effect profile and clinical studies].

  2002cites this paper
• Risk-Benefit Assessment of Glatiramer Acetate in Multiple Sclerosis

  2001cites this paper
• Natural and experimental transfer of anti-Pertussis antibodies confers resistance to experimental autoimmune encephalomyelitis.

  1993cites this paper
• Copolymer-I therapy for multiple sclerosis.

  1987cites this paper
• Immunosuppression in Experimental Allergic Encephalomyelitis

  1987cites this paper
• Antigen structure and immunogenicity.

  1982cites this paper
• Multiple sclerosis: Trial of a synthetic polypeptide

  1982cites this paper
• The significance of abnormal immune responses in patients with multiple sclerosis.

  1981cites this paper
• Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis.

  1980cites this paper
• Failure of myelin basic protein to prevent or suppress experimental allergic encephalomyelitis in guinea pigs

  1980cites this paper
• A Synthetic Copolymer of Amino Acids in a Clinical Trial for MS Therapy

  1980cites this paper
• Failure of basic protein therapy for multiple sclerosis

  1977cites this paper
• Regulation of autosensitisation to encephalitogenic myelin basic protein by macrophage-associated and soluble antigen

  1977cites this paper
• Immunochemistry of Encephalitogenic Protein

  1977cites this paper
• Suppression and reversal of allergic encephalomyelitis in guinea pigs with a non-encephalitogenic analogue of the tryptophan region of the myelin basic protein.

  1976cites this paper
• Durability of immune protection against experimental autoimmune encephalomyelitis.

  1976cites this paper
• Molecular requirements involved in suppression of EAE by synthetic basic copolymers of amino acids.

  1976cites this paper
• Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanism.

  1974cites this paper
• Autoimmune Encephalomyelitis: Activation of Thymus Lymphocytes against Syngeneic Brain Antigens in vitro

  1974cites this paper
• Editorial: Immunologic mysteries of multiple sclerosis.

  1974cites this paper
• Immunologic Mysteries of Multiple Sclerosis

  1974cites this paper
• Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer.

  1974cites this paper
• Is there a cross-reactivity between different parts of the bovine encephalitogenic protein in the macrophage migration inhibition assay?

  1973cites this paper